A Triple Combination Antiviral Coronavirus Therapy (TriACT) for COVID-19

Clinical trial NCT04605588 · TERMINATED

Trial details

NCT number: NCT04605588
Sponsor: Rutgers, The State University of New Jersey
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

SARS-CoV Infection Covid19

Start date: 2020-12-02
Primary completion: 2021-01-17
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.